Oculis Holding AG
OCS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001953530
No open-market purchases or sales by Oculis Holding AG insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $322.0M in total; no superinvestor holds it.
Other share classesOCSAW
Q2 2025 vs. Q1 2025
How the institutions holding Oculis Holding AG changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 20 | 23 | +3 |
| Shares | 4.98M | 5.11M | +127.2K (+2.6%) |
| Value | $94.7M | $99.1M | +$4.36M (+4.6%) |
New holders (6)
Institutions that held Oculis Holding AG at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Woodline Partners LP | 50,568 | $981.5K | 0.01% |
| Marshall Wace, LLP | 20,253 | $393.1K | 0.00% |
| Polen Capital Management LLC | 19,472 | $378.0K | 0.00% |
| Options Solutions, LLC | 19,472 | $378.0K | 0.14% |
| Royal Bank of Canada | 45 | $1.00K | 0.00% |
| Raymond James Financial Inc | 26 | $505 | 0.00% |
Sold out (3)
Institutions that held Oculis Holding AG at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| JPMorgan Chase & Co | 600 | $11.4K |
| Wolverine Asset Management LLC | 399 | $7.59K |
| Tower Research Capital LLC (TRC) | 26 | $495 |